DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Swain SM, Kim SB, Cortes J. et al.
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study.
Lancet Oncol 2013;
14: 461-471
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.